Related by context. All words. (Click for frequent words.) 73 unfavorable cytogenetics 72 adverse cytogenetics 71 antiretroviral naïve 69 smoldering myeloma 69 relapsed ALL 69 % CI #.#-#.# [007] 68 histologically confirmed 68 thrombocytopenic 68 HIV HCV coinfected 68 GH deficiency 68 operable breast cancer 68 acute myeloid 68 Juvenile Idiopathic Arthritis 68 pretransplant 68 recurrent glioblastoma multiforme 68 lymphocytosis 68 relapsed MM 67 FluCAM arm 67 hepatorenal syndrome 67 gastric carcinoma 67 haematologic 67 liver histology 67 HIV coinfected 67 affective psychosis 67 LV dysfunction 67 leukemia AML 67 deletion 5q 66 juvenile idiopathic arthritis 66 hyper IgE syndrome 66 HBeAg negative 66 myelodysplastic myeloproliferative diseases 66 patientswith 66 CP CPPS 66 prostate cancer CaP 66 pancreatic adenocarcinoma 66 stage IIIb IV 66 histologic subtype 66 chronic periodontitis 66 deep venous thromboses 66 diabetes mellitus DM 66 NMIBC 66 elevated LDH 66 metastatic malignant 66 Glioblastoma Multiforme GBM 66 mild renal insufficiency 66 null responder 66 bladder carcinoma 66 aged ≥ 66 tumor histology 66 hemodynamically significant 65 % CI #.#-#.# [003] 65 Charlson comorbidity index 65 juvenile idiopathic arthritis JIA 65 non splenectomized 65 SSc 65 histological subtype 65 BARACLUDE ® 65 comorbid anxiety 65 thyroid carcinoma 65 hepatocellular carcinomas 65 visceral metastases 65 papillary renal cell carcinoma 65 perioperatively 65 hematopoietic cancers 65 portal vein thrombosis 65 smoldering multiple myeloma 65 non metastatic osteosarcoma 65 urolithiasis 65 achieved CCyR 65 lymphomas leukemias 65 basal cell carcinoma BCC 65 LHRH receptor positive 65 prostate carcinoma 65 chronic myeloid 65 relapsed AML 65 follicular lymphoma FL 65 Legg Calvé Perthes disease 65 ALI ARDS 65 Adjuvant chemotherapy 65 MYLOTARG 65 T1DM 65 colorectal liver metastases 65 nonmetastatic 65 immunocompetent 65 hormone receptor negative 65 leucopenia 65 enteroviral infection 65 autoantibody positive 65 Severe Primary IGFD 65 anemia hemoglobin 65 euthymic patients 65 HER2 positive cancers 65 Flu Cy 65 metastatic malignant melanoma 65 biliary tract cancer 64 diffuse gastric 64 proliferative retinopathy 64 relapsing remitting MS RRMS 64 severe mitral regurgitation 64 advanced neoplasia 64 isolated systolic hypertension 64 completely resected 64 Venous thromboembolism 64 hepatitis C genotype 64 euthyroid 64 underwent liver transplantation 64 BRCA mutation carriers 64 EGFR mutation positive 64 BCG vaccinated 64 galiximab 64 atypical hemolytic uremic syndrome 64 K ras mutations 64 Prognostic factors 64 decompensated liver disease 64 PCNSL 64 cranial irradiation 64 nondemented 64 hypereosinophilic syndrome 64 HSCT 64 Asymptomatic 64 Acute myeloid leukemia 64 osteoporotic vertebral compression fractures 64 renal cell carcinomas 64 primary hyperparathyroidism 64 grade cervical intraepithelial 64 overt nephropathy 64 nonalcoholic steatohepatitis NASH 64 moderate renal impairment 64 Waldenstrom macroglobulinemia 64 pT3 64 normal karyotype 64 overactive bladder syndrome 64 underwent resection 64 Bacillus Calmette Guerin BCG 64 alpha1 antitrypsin deficiency 64 recurrent malignant glioma 64 pheochromocytoma 64 ASCUS 64 cytogenetic abnormalities 64 CIN3 64 elevated ALT 64 Chronic lymphocytic leukemia 64 cytomegalovirus infection 64 del 5q 64 Subgroup analysis 64 late onset Pompe 64 undergoing peritoneal dialysis 64 Papillary 64 idiopathic PAH 64 vWD 64 anemia neutropenia 64 hematologic malignancy 64 invasive candidiasis 64 colorectal adenoma 64 ABSSSI 64 ANCA associated 64 CR nPR 63 malignant neoplasm 63 hepatic encephalopathy HE 63 amisulpride 63 nondiabetic patients 63 neovascular form 63 leukemia ALL 63 hypercoagulable 63 symptomatic carotid stenosis 63 Acute Myeloid Leukaemia AML 63 Heterozygous Familial Hypercholesterolemia 63 mRCC 63 Myelodysplastic Syndrome MDS 63 TTR amyloidosis 63 neutropenic sepsis 63 refractory acute myeloid 63 receiving XGEVA 63 CC genotype 63 symptomatic aortic stenosis 63 poststroke 63 HBeAg + 63 metastatic lymph nodes 63 heavily pretreated 63 non squamous histology 63 T2DM 63 metastatic uveal melanoma 63 grade cervical dysplasia 63 psoriatic arthritis PsA 63 microscopic colitis 63 enterocolitis 63 convulsive disorders 63 echocardiographic parameters 63 clinically evaluable 63 cutaneous melanoma 63 #q# deletion syndrome 63 achieved sustained virological 63 vesicoureteral reflux VUR 63 % CI #.#-#.# [008] 63 IPAH 63 eosinophilic asthma 63 autonomic dysfunction 63 lymphocytic leukemia 63 squamous cell carcinoma SCC 63 microbiologically evaluable 63 Infusion Reactions Severe 63 mCRPC 63 osteopenic 63 anagrelide 63 lymphoid malignancies 63 esophageal gastric 63 metastatic gastric 63 KRAS mutations occur 63 refractory Hodgkin 63 pT2 63 severe malignant osteopetrosis 63 PLX STROKE targeting 63 AA Amyloidosis 63 abnormal cytology 63 PPCM 63 nodal metastasis 63 complete cytogenetic response 63 HGPIN 63 squamous cell histology 63 cutaneous squamous cell carcinoma 63 HBeAg negative patients 63 neovascular glaucoma 63 pulmonary hypertension PH 63 squamous histology 63 polyarticular 63 neurological manifestations 63 unresectable tumors 63 antiphospholipid syndrome 63 underwent CABG 63 malignant ascites 63 hyperoxaluria 63 liver metastasis 63 postoperative delirium 63 REYATAZ r arm 63 idiopathic pulmonary arterial hypertension 63 haematological malignancies 63 primary aldosteronism 63 nodal metastases 63 thymoma 63 dermatologic reactions 63 adjuvant cisplatin 63 myeloproliferative neoplasms 63 T1a 63 refractory colorectal cancer 63 mutated K ras 63 BEXXAR Therapeutic Regimen 63 chronic renal insufficiency 63 liposomal amphotericin B 63 Breslow thickness 63 macroalbuminuria 63 Stent thrombosis 63 advanced adenoma 63 FOLFIRI alone 63 myeloproliferative diseases 63 immunocompetent adults 62 ALT flares 62 metastatic bladder 62 MELAS 62 ara C 62 nonhereditary 62 â ‰ ¥ 62 morphometric vertebral fractures 62 ELBW infants 62 subependymal giant cell 62 bone marrow reticulin deposition 62 onset diabetes mellitus 62 prospectively enrolled 62 KRAS mutant tumors 62 atrioventricular block 62 comorbid disorders 62 ovarian carcinoma 62 colorectal neoplasms 62 Acute Coronary Syndromes ACS 62 receiving VELCADE 62 acute myelogenous leukemia AML 62 haematological 62 Intravenous immunoglobulin 62 neoplasias 62 KRAS wild 62 recurrent NSCLC 62 clinically asymptomatic 62 invasive carcinoma 62 metastatic GIST 62 somatostatin analog 62 Non Alcoholic Steatohepatitis 62 CCyR 62 minimally symptomatic 62 ECOG PS 62 Primary IGFD 62 immune thrombocytopenic purpura ITP 62 % CI #.#-#.# [006] 62 acute aortic dissection 62 stratifying patients 62 HeFH 62 treatment naive genotype 62 International Prognostic Scoring 62 CLL SLL 62 Ribavirin causes 62 neurologic impairment 62 postoperative AF 62 idiopathic myelofibrosis 62 medically inoperable 62 haematopoietic stem cell 62 metastatic renal 62 pulmonary dysfunction 62 lymphoproliferative disorders 62 TNF blocker therapy 62 extracapsular extension 62 neurologic complications 62 Gleevec resistant 62 Cloretazine 62 histologically proven 62 CTEPH 62 Postoperatively 62 Acute Myelogenous Leukemia AML 62 retrospective cohort 62 osteosarcomas 62 Eisenmenger syndrome 62 Glioblastoma Multiforme 62 renal scarring 62 PNH patients 62 squamous cell lung cancer 62 pamidronate 62 G6PD deficiency 62 Atypical Hemolytic Uremic Syndrome 62 biochemical relapse 62 neurodevelopmental impairment 62 ACTEMRA TM 62 SGPT 62 CIN2 + 62 recurrent metastatic 62 HIV seronegative 62 HER2 overexpression 62 antiretroviral naive 62 Stage IIB 62 astrocytomas 62 Hurthle cell 62 hematologic toxicity 62 decompensated heart failure 62 relapsed Acute Myeloid 62 lymphopenia 62 gastric adenocarcinoma 62 unstable angina pectoris 62 chronic immune thrombocytopenic 62 comorbid illnesses 62 childhood acute lymphoblastic 62 erythema nodosum 62 AML MDS 62 tumor subtype 62 hyperphenylalaninemia HPA due 62 bacterial prostatitis 62 chemoradiation therapy 62 HIV seropositive 62 p# biomarker 62 immunocompetent patients 62 breast carcinoma 62 undergoing liver transplantation 62 methotrexate monotherapy 62 immunosuppression therapy 62 choroidal vasculopathy 62 idiopathic membranous nephropathy 62 HIV uninfected 62 fructose intolerance 62 progressive PsA 62 Sjögren syndrome 62 allogeneic hematopoietic stem cell 62 rituximab refractory 62 Adenomas 62 carotid stenosis 62 C1 INH deficiency 62 Chronic Myeloid Leukaemia 62 metastatic neuroendocrine tumors 62 de novo kidney transplant 62 seropositivity 62 intracerebral haemorrhage 62 pCR 62 bronchopulmonary dysplasia BPD 62 hypovitaminosis D 62 Idiopathic Pulmonary Fibrosis 62 genotype 1b 62 LHON 62 CIMZIA TM certolizumab pegol 62 bronchogenic carcinoma 62 elevated troponin 62 acute lymphoblastic 62 transaminase elevations 62 pancreatic prostate 62 HER2 expression 62 adjunctive placebo 62 systemic JIA 61 metaplasia 61 Hodgkin lymphoma HL 61 nonischemic 61 chronic rheumatic 61 noncardiac 61 HLA DR4 61 ß blockers 61 systemic corticosteroid 61 dual endothelin receptor antagonist 61 neurologic sequelae 61 decompensated cirrhosis 61 invasive aspergillosis 61 Relapsing remitting MS 61 HBeAg 61 nonsevere 61 thyrotoxicosis 61 postoperative chemotherapy 61 leukemia lymphomas 61 unresectable recurrent 61 mild hepatic impairment 61 acute mania 61 infective endocarditis 61 myeloproliferative disorder 61 kidney urologic 61 lupus erythematosus 61 perioperative complications 61 weekly subcutaneous injections 61 thromboembolic complications 61 cirrhotic 61 refractory anaplastic astrocytoma 61 cervical lymph nodes 61 leukaemias 61 SNT-MC#/idebenone 61 Leukemias 61 allogeneic bone marrow 61 artery stenosis 61 Chronic Heart Failure 61 Known hypersensitivity 61 antithymocyte globulin 61 stage IIIb 61 cytopenias 61 nucleoside naive 61 systemic lupus erythematosus SLE 61 PPSV# 61 mycosis fungoides 61 sensory neuropathy 61 Sezary syndrome 61 mycophenolate 61 unstable angina UA 61 antiphospholipid antibodies 61 relapsed acute myelogenous 61 postintervention 61 nonalcoholic steatohepatitis 61 GOUT 61 demonstrated antitumor activity 61 TroVax ® 61 nonvertebral fracture 61 confidence interval #.#-#.# 61 naïve HCV 61 receiving Vectibix monotherapy 61 Follicular Lymphoma 61 ragweed allergic 61 G CSFs 61 HBeAg positive patients 61 ALT elevations 61 receiving highly emetogenic 61 venous thromboembolic disease 61 stage IIIA 61 antibody titer 61 Soft Tissue Sarcoma 61 immune thrombocytopenic purpura 61 rALLy 61 EoE 61 LVNC 61 postoperative complication 61 TT genotype 61 paricalcitol 61 NNRTI resistance 61 bortezomib refractory 61 Surgical resection 61 Systemic Lupus Erythematosus SLE 61 PNET 61 T1c 61 Familial Hypercholesterolemia 61 PSA nadir 61 hematological malignancy 61 epithelial tumors 61 PsA 61 intraventricular hemorrhage 61 interstitial pneumonia 61 severe exacerbations 61 Cutaneous T 61 Kinoid 61 angiographically 61 diagnosed Ph + 61 surgically resectable 61 hypophosphatemia 61 transthyretin amyloidosis 61 BRAF V#E mutation 61 follicular lymphomas 61 femoral neck fracture 61 multivariable adjusted 61 prostate adenocarcinoma 61 preintervention 61 Juvenile Idiopathic Arthritis JIA 61 symptomatic intracranial 61 poor metabolizers 61 clinicopathological 61 precancerous cervical 61 Hurler syndrome 61 genotypic resistance 61 Renal Cell Carcinoma RCC 61 certolizumab 61 malignant pleural mesothelioma 61 untreated AML 61 metastatic lung cancer 61 dyslipidemia hypertension diabetes 61 underwent surgical resection 61 recurrent glioblastoma 61 localized renal 61 MGd 61 tipranavir ritonavir 61 renal tumors 61 basal cell nevus syndrome 61 sinus node dysfunction 61 bladder ovarian 61 prospectively evaluated 61 CYP#D# genotype 61 refractory ovarian cancer 61 monozygotic twin 61 myeloid metaplasia 61 tumor lysis syndrome 61 chronic eosinophilic leukemia 61 abdominal irradiation 61 occlusive disease 61 Myelodysplastic syndromes 61 relapsing multiple sclerosis 61 chronic HBV 61 CANCIDAS 61 hypercalciuria 61 azilsartan medoxomil 61 idiopathic scoliosis 61 arterial thromboembolic events 61 serum urate levels 61 Autoimmune hepatitis 61 ER CHOP 61 Genetic susceptibility 61 neurodevelopmental outcomes 61 diabetic kidney 61 MMSE scores 61 cisplatin chemotherapy 61 subcutaneous immunoglobulin 61 extensive metabolizers 61 System IPSS 61 renal carcinoma 61 RBC transfusion 61 recurrent UTI 61 bacteraemia 61 tumors GIST 61 psychiatric comorbidities 61 Chronic lymphocytic leukemia CLL 61 oral antidiabetic medication 61 hemodynamically stable 61 stage IIIB 61 endoscopic ultrasonography 61 non splenectomised 61 supratentorial 61 del 5q MDS 61 Synovial sarcoma 61 Chronic ITP 61 monoclonal gammopathy 61 ORENCIA ® 61 rheumatologic 61 gemcitabine carboplatin 61 neurosensory 61 urothelial carcinoma 61 endometrioid 61 recurrent glioma 61 Aortic stenosis 61 neutropaenia 61 Newly Diagnosed Multiple Myeloma 61 atypical Hemolytic Uremic Syndrome 61 hypokalemia hypomagnesemia 61 taxane therapy 61 mucinous 61 Arch Intern Med 61 attain statistical significance 61 malignant neoplasms 61 8mg/kg 61 Non inferiority 61 cholangiocarcinoma 61 ventricular dysfunction 61 atopic asthma 61 endocrine therapies 61 Renal dysfunction 61 leiomyomas 61 Hematologic 61 adult chronic ITP 61 BRCA1 mutation carriers 61 induce orthostatic hypotension 61 hypogonadotropic hypogonadism 61 chronic idiopathic 61 nicardipine 61 allogeneic transplants 61 secondary hyperparathyroidism 61 paraganglioma 61 abacavir Ziagen 61 prognostic indicators 61 preoperative PSA 61 thalassemia sickle cell 61 prognostic variables 61 Operative mortality 61 hyperparathyroidism 61 β blockers 61 elevated triglyceride levels 60 Lennox Gastaut syndrome 60 ‰ ¥ 60 invasive lobular 60 monoinfected patients 60 receiving VICTRELIS 60 renal artery stenosis 60 Myelodysplastic Syndrome 60 carotid artery blockage 60 Wilms tumors 60 essential thrombocythemia ET 60 mcg kg REBETOL 60 Acute Myelogenous Leukemia 60 ADPKD 60 idiopathic thrombocytopenic purpura 60 folinic acid 60 LRTI 60 polycythemia vera essential thrombocythemia 60 pulmonary metastasis 60 lamivudine refractory patients 60 INVEGA ® 60 renal allograft 60 cirrhotic patients 60 unresectable stage 60 osteopetrosis 60 congenital deficiency 60 hyperacute 60 neutropenia dehydration dyspnea 60 femoral neck fractures 60 graft dysfunction 60 miglustat 60 RET PTC rearrangements 60 chronic GVHD 60 limiting generalizability 60 EpCAM expression 60 myelogenous leukemia 60 herpes zoster shingles 60 leukocytosis 60 tipranavir r 60 metastatic kidney 60 Squamous 60 posttransplant 60 severe neutropenia 60 candidemia 60 aortic atherosclerosis 60 neurogenic bladder 60 axillary node 60 receptor tyrosine kinase inhibitor 60 prospectively stratified 60 TNF antagonist 60 haematological cancers 60 colorectal carcinoma 60 lumbar disk herniation 60 pediatric Crohn disease 60 micafungin 60 urethral stricture 60 primary IGFD 60 PASI scores 60 dalteparin 60 thetreatment 60 incomplete revascularization 60 serous ovarian cancer 60 Ischemic 60 methotrexate therapy 60 SJIA 60 paroxysmal atrial fibrillation 60 metastatic renal cell 60 curative therapy 60 pemphigus vulgaris 60 total thyroidectomy 60 geographic atrophy 60 severe hepatic dysfunction 60 hereditary deficiency 60 systolic hypertension 60 Chronic Myelogenous Leukemia 60 VaD 60 R entecavir 60 locoregional recurrence 60 osteoporotic compression fractures 60 bullous 60 bronchial hyperresponsiveness 60 gastrointestinal stromal tumor GIST 60 interferon ribavirin 60 oropharyngeal candidiasis OPC 60 IBS C 60 MYCN amplification 60 Peginterferon alfa 2b 60 neoadjuvant treatment 60 QTcF 60 Retreatment 60 HYVET 60 Febrile neutropenia 60 treating sarcoma testicular 60 papillary carcinoma 60 Pegylated Liposomal Doxorubicin 60 microsatellite instability 60 Ph + acute lymphoblastic 60 bronchoalveolar 60 intravascular hemolysis 60 mcg BID 60 Folfox 60 radioiodine therapy 60 heFH 60 anthracyclines taxanes 60 Castration Resistant Prostate Cancer 60 Intra arterial 60 antiangiogenic therapy 60 ependymoma 60 infantile onset 60 acute cholecystitis 60 Cell Lymphoma CTCL 60 allogeneic HSCT 60 BI/NAP#/# 60 intracranial hypertension 60 rFVIIa 60 coagulation abnormalities 60 sacral neuromodulation 60 chorioamnionitis 60 asymptomatic PAD 60 melphalan prednisone 60 elacytarabine 60 psoriasis vulgaris 60 resectable pancreatic cancer 60 myelomeningocele 60 corticosteroid induced 60 chronic hepatitis cirrhosis 60 transfusion syndrome 60 Helicobacter pylori eradication 60 EXJADE 60 PAOD 60 BPS IC 60 chronic granulomatous disease 60 arteriography 60 recurrent venous thromboembolism 60 taxane refractory 60 atherosclerotic renal artery stenosis 60 severe periodontitis 60 clinicopathological features 60 sJIA 60 mildly symptomatic 60 liver transplant recipients 60 eculizumab therapy 60 immunodeficient 60 HBeAg positive 60 patients undergoing CABG 60 receiving immunosuppressive therapy 60 syngeneic 60 SPRYCEL ® 60 Malignant Glioma 60 diagnostic angiography 60 ALT elevation 60 beta blocker therapy 60 acromegalic patients 60 relapsed refractory AML 60 adjuvant tamoxifen 60 invasive lobular carcinoma 60 known sulfonamide allergy 60 HNSCC 60 nondiabetic 60 baseline LDH 60 EDSS scores 60 polyp recurrence 60 metastatic renal cell carcinoma 60 transrectal ultrasound guided 60 Hip fracture 60 autologous transplants 60 everolimus eluting stents 60 reduce serum phosphate 60 pneumocystis carinii pneumonia 60 pathologic fractures 60 recurrent genital herpes 60 mutated KRAS 60 lipid elevations 60 polyposis 60 liver enzymes ALT 60 NOMID 60 BR.# 60 GISTs 60 moderately emetogenic 60 primary immunodeficiency PI 60 nulliparous women 60 MALT lymphoma 60 #mg BID [001] 60 Systemic Sclerosis 60 Relapsing Remitting Multiple Sclerosis 60 Ophena TM 60 haematologic malignancies 60 interferon beta therapy 60 MenACWY 60 locoregional 60 TAXUS Express Stent 60 aplasia 60 neutropenic fever 60 concomitant AEDs 60 seronegative 60 carcinoid tumors 60 mitoxantrone plus 60 Sudhir Agrawal D.Phil 60 esotropia 60 gastroduodenal 60 autoimmune thyroiditis 60 SCr 60 thrombophilia 60 seroprotection 60 genitourinary GU 60 pulmonary metastases 60 Patients Treated With 60 undergoing CABG 60 GBA mutations 60 kidney allograft 60 mitral stenosis 60 Nilotinib 60 esophageal candidiasis 60 Heavy menstrual bleeding 60 Amgen Neulasta ® 60 nonmelanoma 60 allogenic stem cell 60 hepatectomy 60 leukopenia 60 clinically detectable 60 symptomatic hyponatremia 60 BRCA2 carriers 60 overt hepatic encephalopathy HE 60 lesional 60 NIDDM 60 relapsed refractory multiple myeloma 60 dyskeratosis congenita 60 HLA A2 60 peritoneal carcinomatosis 60 Vitamin B# deficiency 60 eribulin mesylate 60 Langerhans cell histiocytosis 60 achieved ACR# 60 diffuse intrinsic pontine glioma 60 lenalidomide Revlimid R 60 leptin deficiency 60 fibroids endometriosis 60 generalized epilepsy 60 symptomatic VTE 60 treated nonsurgically 60 cryptogenic stroke 60 familial clustering 60 BENICAR HCT 60 Staphylococcus aureus infections 60 pheochromocytomas 60 adrenalectomy 60 CCR5 tropic HIV 60 BARACLUDE r 60 cytogenic 60 opioid naive 60 anthracycline containing 60 FDA defined valvulopathy 60 untreated multiple myeloma 60 acute subacute 60 diabetic polyneuropathy 60 generalized tonic clonic seizures 60 Fanconi syndrome 60 paroxysmal AF 60 immunodeficiency disorders 60 CALGB # [002] 60 multivariable analyzes 60 Diffuse Large B 60 differentiated thyroid 60 renal transplants 60 purpura 60 imatinib resistant 60 allogeneic hematopoietic cell 60 bacteremic 60 Hepatocellular Carcinoma HCC 60 neoadjuvant setting 60 Philadelphia Chromosome Positive 60 reactogenicity 60 salmeterol fluticasone 60 renal insufficiency 60 nonmelanoma skin cancers 60 adnexal mass 60 DBMD 60 prostate cancer PCa 60 renal biopsy 60 Relapsed Refractory 59 underwent radical prostatectomy 59 venlafaxine XR 59 hepatic metastases 59 advanced adenomas 59 alanine aminotransferase 59 syncopal episodes 59 neurocognitive impairment 59 Acute Renal Failure 59 onset seizures 59 EGFR mutation status 59 HBV infections 59 gonococcal 59 paclitaxel eluting stents 59 subclinical hypothyroidism 59 hepatic dysfunction 59 urothelial cancer 59 Mitomycin C 59 adenomyosis 59 Certolizumab pegol 59 intravenous bisphosphonates 59 headache abdominal pain 59 definite stent thrombosis 59 vesicoureteral reflux 59 CHAMPION PCI 59 varicella infection 59 neuromotor 59 underactive thyroids 59 intestinal metaplasia 59 Pharmacokinetics PK 59 Hp2 2 59 seminoma 59 HLA DR2 59 relapsed SCLC 59 HBsAg 59 squamous 59 clinicopathologic 59 hypervascular 59 fasting triglyceride levels 59 noninferior 59 essential thrombocythemia 59 hsCRP levels 59 discontinued Viread 59 oral clodronate 59 pancreatic fistula 59 multicenter randomized controlled 59 coinfected patients 59 postoperative morbidity 59 Bronchiectasis 59 proctitis 59 aspartate aminotransferase AST 59 Brugada syndrome 59 hepatocellular cancer 59 receiving TNF blockers 59 Scheuermann kyphosis 59 endometrial hyperplasia 59 tricuspid regurgitation 59 somatization disorder 59 anaplastic astrocytomas 59 containing abacavir 59 advanced medullary thyroid 59 B Cell Lymphoma 59 mucosal inflammation 59 carcinoid 59 CHD mortality 59 nontraumatic 59 nonobese 59 thymectomy 59 castrate resistant prostate cancer 59 SLNB 59 adjuvant radiotherapy 59 oesophageal adenocarcinoma 59 CTAP# 59 recurrent ischemia 59 BRAF V#E 59 systemic amyloidosis 59 poorer prognosis 59 Adjunctive 59 pulmonary artery banding 59 chronic hemodialysis 59 external genital lesions 59 vaso occlusive crisis 59 Myelodysplastic syndromes MDS 59 skeletal metastases 59 refractory CLL 59 Thal Dex 59 intracranial hemorrhage ICH 59 Ishak fibrosis score 59 autologous SCT 59 nonproliferative 59 previously untreated follicular 59 evaluable subjects 59 chronic HCV genotype 59 intravenous RSD# 59 OSAHS 59 CHD CVD 59 Doxil ® 59 myocardial infarction ventricular fibrillation 59 metastatic dermatofibrosarcoma protuberans DFSP 59 underwent coronary angiography 59 arterial thromboembolic 59 intestinal polyps 59 multiple myeloma MM 59 grade squamous intraepithelial 59 comparator arm 59 lung fibrosis 59 undergoing radical cystectomy 59 medullary thyroid carcinoma 59 demyelinating 59 splenectomized 59 indolent lymphomas 59 stem cell engraftment 59 follicular thyroid cancer 59 Rate ORR 59 adalimumab Humira 59 sarcomatoid